Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Euronext Paris
06:27:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 194.60 EUR | -0.36% |
|
+1.35% | -7.33% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 19B 22.03B 17.87B 16.28B 30.62B 2,091B 30.79B 211B 82.25B 1,063B 82.71B 80.91B 3,526B | P/E 2026 * |
49.8x | P/E 2027 * | 38.7x |
|---|---|---|---|---|---|
| Enterprise Value | 21.03B 24.38B 19.79B 18.03B 33.9B 2,314B 34.08B 234B 91.04B 1,177B 91.55B 89.57B 3,903B | EV / Sales 2026 * |
6.73x | EV / Sales 2027 * | 5.99x |
| Free-Float |
28.47% | Yield 2026 * |
0.43% | Yield 2027 * | 0.52% |
Last Transcript : Sartorius Stedim Biotech
| 1 day | -0.92% | ||
| 1 week | +0.78% | ||
| Current month | -1.28% | ||
| 1 month | +12.57% | ||
| 3 months | +9.69% | ||
| 6 months | +7.68% | ||
| Current year | -7.86% |
| 1 week | 190.5 |  | 200.2 |
| 1 month | 166 | | 200.2 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | +0.78% | +12.14% | -26.40% | 22.03B | |
| -1.30% | -6.20% | -17.89% | +5.91% | 188B | |
| +1.53% | +0.99% | -0.83% | +12.07% | 118B | |
| +2.28% | +0.89% | +13.50% | +89.17% | 63.16B | |
| -1.89% | -2.18% | +26.20% | +48.54% | 52.01B | |
| -0.53% | -1.40% | -3.04% | -32.80% | 50.97B | |
| -1.01% | +1.10% | +19.64% | -11.54% | 34.02B | |
| +0.23% | -1.49% | - | - | 30.8B | |
| -0.72% | -2.82% | +37.13% | -16.93% | 23.83B | |
| -2.97% | -4.00% | -7.37% | +13.67% | 23.45B | |
| Average | -0.53% | -1.44% | +8.83% | +9.08% | 60.66B | |
| Weighted average by Cap. | -0.30% | -2.49% | +0.41% | +13.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.62B 2.94B 2.68B 5.04B 344B 5.07B 34.77B 13.53B 175B 13.61B 13.31B 580B | 3.47B 4.02B 3.26B 2.97B 5.59B 382B 5.62B 38.57B 15.01B 194B 15.1B 14.77B 644B |
| Net income | 381M 442M 359M 327M 615M 41.96B 618M 4.24B 1.65B 21.34B 1.66B 1.62B 70.77B | 483M 560M 454M 414M 779M 53.16B 783M 5.37B 2.09B 27.04B 2.1B 2.06B 89.66B |
| Net Debt | 2.03B 2.36B 1.91B 1.74B 3.27B 224B 3.29B 22.59B 8.79B 114B 8.84B 8.65B 377B | 1.79B 2.07B 1.68B 1.53B 2.88B 197B 2.9B 19.88B 7.74B 100B 7.78B 7.61B 332B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | €194.60 | -0.36% | 11,546 |
| 26-09-01 | €195.30 | -0.36% | 120,335 |
| 26-08-31 | €196.00 | -0.86% | 219,124 |
| 26-08-28 | €197.70 | +0.51% | 56,919 |
| 26-08-27 | €196.70 | +2.45% | 65,436 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
